TrendFlares logo

Avenue Therapeutics, Inc. (ATXI)

$2.79 -1.76% $-0.05 Healthcare

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

$3.99M

Dr. Lindsay Allan Rosenwald

4.00

New York, NY

Jun 27, 2017

0.07

$37.48

4.24

4.30

0.00%

-0.30

-0.00

0.66

0.00

4.30

-207.70%

-749.10%

Downtrend

Similar stocks (10)

NeuroBo Pharmaceuticals, Inc.

NRBO

$3.44 -4.71%
Downtrend

Hoth Therapeutics, Inc.

HOTH

$1.01 -8.18%
Downtrend

CNS Pharmaceuticals, Inc.

CNSP

$0.15 2.43%
Downtrend

Allarity Therapeutics, Inc.

ALLR

$3.36 -1.47%
Downtrend

Palisade Bio, Inc.

PALI

$3.89 2.64%
Downtrend

Kiromic BioPharma, Inc.

KRBP

$1.80 -11.33%
Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.62 3.21%
Downtrend

Windtree Therapeutics, Inc.

WINT

$3.17 0.00%
Downtrend

Panbela Therapeutics, Inc.

PBLA

$0.34 1.52%
Downtrend

Revelation Biosciences, Inc.

REVB

$0.90 -0.65%
Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$178.36 0.55%
Uptrend